Volume | 0 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Bio Rad Laboratories Inc | BIO | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
280.13 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 261.59 - 473.50 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 280.13 | USD |
Bio Rad Laboratories (BIO) Options Flow Summary
Bio Rad Laboratories Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
7.98B | 28.52M | - | 2.67B | -637.32M | -22.35 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Bio Rad Laboratories News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BIO Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 297.57 | 299.22 | 268.916 | 283.99 | 259,170 | -17.44 | -5.86% |
1 Month | 342.77 | 350.90 | 268.916 | 311.69 | 200,525 | -62.64 | -18.27% |
3 Months | 330.44 | 364.24 | 268.916 | 327.07 | 204,609 | -50.31 | -15.23% |
6 Months | 309.00 | 364.24 | 261.59 | 313.22 | 245,855 | -28.87 | -9.34% |
1 Year | 466.64 | 473.50 | 261.59 | 343.78 | 225,630 | -186.51 | -39.97% |
3 Years | 641.60 | 832.70 | 261.59 | 468.20 | 188,864 | -361.47 | -56.34% |
5 Years | 293.00 | 832.70 | 261.59 | 456.02 | 199,729 | -12.87 | -4.39% |
Bio Rad Laboratories Description
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier. |